Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA 2017 | Clinical update: lung and pancreatic cancer

Islam Elkonaissi • 6 Oct 2017
BOPA 2017
Lung Cancer Pancreatic Cancer

Exciting clinical updates for lung and pancreatic cancer were presented at the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK. In this interview, Islam Elkonaissi of The Royal Marsden NHS Foundation Trust, London, UK, gives a summary of the highlights from these sessions, including novel immunotherapies and the role of pharmacists in championing these.

More from Islam Elkonaissi

2:30
Bringing oncology pharmacists together: 10 years forward
Islam Elkonaissi • 10 Oct 2019
4:48
Minimizing the risk of steroid-induced hyperglycemia in NSCLC patients receiving immunotherapy
Islam Elkonaissi • 10 Oct 2019
1:49
The role of pharmacists in utilizing novel pancreatic cancer treatments
Islam Elkonaissi • 6 Oct 2017
1:58
Multidisciplinary cancer research: overcoming the odds
Islam Elkonaissi • 6 Oct 2017

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The benefits of liquid biopsies for lung cancer in the community setting
Deepti Behl • 9 Apr 2024
1:16
Entinostat with nivolumab in pancreatic ductal adenocarcinoma
Marina Baretti • 9 Apr 2024
0:40
The limited therapeutic efficacy of checkpoint inhibitors for pancreatic cancer
Olatunji Alese • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals